EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Hemoglobin as a Molecular Glue: Toward Potent Inhibition of HbS Polymerization in Sickle Cell Disease

Mohammad Edrisi, Navid Rabiee iD

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.202504346 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Mohammad Edrisi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Hemoglobin, Sickle, Hemoglobins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 116 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sickle cell disease (SCD), a monogenic disorder arising from a single point mutation in the β‐globin gene, continues to pose a significant global health burden despite advances in supportive care. This mutation drives the formation of hemoglobin S (HbS) polymers under deoxygenated conditions, causing erythrocyte sickling, vaso‐occlusive crises, and multi‐organ complications. Current therapies, such as hydroxyurea and voxelotor, provide only partial symptomatic relief, underscoring the urgent need for transformative strategies. This review highlights the molecular glue paradigm, a novel approach that repurposes hemoglobin itself as a therapeutic scaffold. By integrating high‐resolution structural insights from cryo‐electron microscopy and predictive modeling via artificial intelligence, engineered hemoglobin variants can be rationally designed to inhibit polymerization, stabilizing non‐pathogenic conformations and preventing fiber formation. These molecular glues, generated through gene editing or synthetic biology, offer a cell‐intrinsic, high‐concentration mechanism to counteract HbS polymerization, potentially overcoming the limitations of current therapies. We examine the key challenges in translating this paradigm, including precise structural characterization of polymerization intermediates, efficient intracellular delivery to erythrocytes, temporal regulation under hypoxic conditions, and the mitigation of immunogenicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellHemoglobin, SickleHemoglobinsHumansAnimalsPolymerization

Stichwörter der Autor:innen

hemoglobinmolecular gluemolecular pathogenesissickle cell disease

Substanzen

Hemoglobin, SickleHemoglobins

Autor:innen und Institutionen

  • Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran.
  • Department of Biomaterials, Saveetha Dental College and Hospitals, SIMATS, Saveetha University, Chennai, India.

ORCID-Profile: Navid Rabiee

Zitieren

APA

Edrisi, M., & Rabiee, N. (2026). Hemoglobin as a Molecular Glue: Toward Potent Inhibition of HbS Polymerization in Sickle Cell Disease. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202504346

Vancouver

Edrisi M, Rabiee N. Hemoglobin as a Molecular Glue: Toward Potent Inhibition of HbS Polymerization in Sickle Cell Disease. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202504346

BibTeX
@article{Edrisi2026,
  author = {Edrisi, Mohammad and Rabiee, Navid},
  title = {Hemoglobin as a Molecular Glue: Toward Potent Inhibition of HbS Polymerization in Sickle Cell Disease},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.202504346}
}
Kostenlos starten →